Biovie
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -57 | -57 | -57 | -57 |
EBITDA | -5,071 | -3,426 | -2,930 | -7,235 |
EBIT | -5,129 | -3,484 | -2,988 | -7,292 |
Net Income | -5,131 | -3,489 | -2,788 | -7,112 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,023 | -5,607 | -1,253 | -8,584 |
Cash | 24,978 | 17,544 | 23,152 | 24,405 |
Basic Shares | 5,214 | 14,773 | 1,850 | 1,571 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -229 | -229 | -266 | -237 |
EBITDA | -16,980 | -31,950 | -45,726 | -27,023 |
EBIT | -17,209 | -32,179 | -45,955 | -27,252 |
Net Income | -17,542 | -32,120 | -50,255 | -26,084 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 14,130 | |||
Free Cash Flow | -19,025 | -27,945 | -40,252 | -18,990 |
Cash | 17,544 | 23,843 | 19,460 | 18,641 |
Basic Shares | 1,477 | 451 | 324 | 246 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.98 |
2025-06-30 | -$11.05 |
2025-03-31 | -$1.50 |
2024-12-31 | -$4.60 |
